CMC-hiPSC-003(Sox1-GFP), CMC-003i-Sox1.EGFP
KSCBi005-A-2
General
Cell Line |
|
| hPSCreg name | KSCBi005-A-2 |
| Cite as: | KSCBi005-A-2 (RRID:CVCL_WR12) |
| Alternative name(s) |
CMC-hiPSC-003(Sox1-GFP), CMC-003i-Sox1.EGFP
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines |
KSCBi005-A (CMC-hiPSC-003) KSCBi005-A-1 (CMC-hiPSC-003(Nestin-GFP), CMC-003i-Nestin.EGFP) KSCBi005-A-3 (CMC-003i-Pdx1.EGFP, CMC-hiPSC-003(PDX1-GFP)) |
| Last update | 6th August 2019 |
| User feedback | |
Provider |
|
| Generator | National Stem Cell Bank (KSCB) |
| Owner | National Stem Cell Bank (KSCB) |
| Distributors | |
| Derivation country | South Korea |
External Databases |
|
| BioSamples | SAMEA5837725 |
| Cellosaurus | CVCL_WR12 |
| Wikidata | Q95980254 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
| Subclone of | |
Donor Information
General Donor Information |
|
| Sex | male |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
Karyotyping (Donor) |
|
| Has the donor karyotype been analysed? |
Yes
46, XY
Karyotyping method:
G-Banding
|
External Databases (Donor) |
|
| BioSamples | SAMEA5713593 |
Ethics
Also have a look at the ethics information for the parental line
KSCBi005-A
.
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
|
The source cell information can be found in the parental cell line
KSCBi005-A.
|
|
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Sendai virus |
| Genes | |
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Yes |
| Derived under GMP? |
No |
| Available as clinical grade? |
No |
Culture Conditions
| Surface coating | Vitronectin |
| Feeder cells |
No |
| Passage method |
Enzyme-free cell dissociation
EDTA
|
| Medium |
TeSR™ E8™
|
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | No |
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No |
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes |
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| NANOG |
Yes |
|
||||
| POU5F1 (OCT-4) |
Yes |
|
||||
| SOX2 |
Yes |
|
||||
| GDF3 |
Yes |
|
||||
| TERT |
Yes |
|
||||
| ZFP42 (REX-1) |
Yes |
|
||||
| POU5F1 (OCT-4) |
Yes |
|||||
| SSEA-4 |
Yes |
|||||
| TRA 1-60 |
Yes |
|||||
| TRA 1-81 |
Yes |
|||||
| Alkaline Phosphatase |
Yes |
Differentiation Potency
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
46, XY
Karyotyping method:
G-Banding
|
Other Genotyping (Cell Line) |
|
Genetic Modification
| Genetic modifications not related to a disease |
|


Login to share your feedback, experiences or results with the research community.